NCT04677751 Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients With Acupuncture Treatment
| NCT ID | NCT04677751 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2021-04-01 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS System
Eligibility Criteria
Inclusion Criteria: * Patient implanted with the RNS system * Patient can undergo 12 weeks of acupuncture * Patient is able remain on stable medications for 12 weeks * Patient is able to remain on stable Detection and Stimulation settings for 12 weeks * Patient or/and caregiver is able to understand and sign informed consent and HIPAA authorization * Patient or caregiver able to maintain a seizure diary for duration of study Exclusion Criteria: * Patient and /or caregiver is unable to sign informed consent to study * Patient has a bleeding disorder, pacemaker, or pregnant
Contact & Investigator
Olga Rodziyevska, MS,PA-C
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT04677751 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 60 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04677751 currently recruiting?
Yes, NCT04677751 is actively recruiting participants. Contact the research team at Olga.Rodziyevska@uth.tmc.edu for enrollment information.
Where is the NCT04677751 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT04677751 clinical trial?
NCT04677751 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Olga Rodziyevska, MS,PA-C at The University of Texas Health Science Center, Houston. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.